<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7122828/results/search/drug/results.xml">
  <result pre="al. 2005). In 1820, Pierre Pelletier and Joseph Caventau isolated" exact="quinine" post="from Cinchona sp., proved its antimalarial effect, and in"/>
  <result pre="sp., proved its antimalarial effect, and in the next year," exact="quinine" post="and quinine sulfate were commercially available as the first"/>
  <result pre="its antimalarial effect, and in the next year, quinine and" exact="quinine" post="sulfate were commercially available as the first antimalarial drugs"/>
  <result pre="al. 2006; FioCruz 2017). Up to the I World War," exact="quinine" post="was the only drug used to treat malaria. The"/>
  <result pre="also driven by the inherent difficulties for the extraction of" exact="quinine" post="from the bark of Cinchona, the United States started"/>
  <result pre="impossible (Lee 2002). The failures in the laboratory synthesis of" exact="quinine" post="greatly motivated researches for the prospection of new antimalarial"/>
  <result pre="new antimalarial drugs such as Amodiaquine, Primaquine, Proguanil, Pyrimethamine, and" exact="Chloroquine" post="(Boss et al. 2003; Ockenhouse et al. 2005; Silva"/>
  <result pre="al. 2003; Ockenhouse et al. 2005; Silva et al. 2005)." exact="Chloroquine" post="has been highlighted among these drugs due to its"/>
  <result pre="possibility of being consumed by pregnant women. These advantages made" exact="chloroquine" post="the first choice in the treatment of malaria (Robert"/>
  <result pre="tropical diseases, especially malaria. In the 1970s, Chinese researchers presented" exact="artemisinin" post="and its semisynthetic derivatives (Artemether, Arteether, Artesunate, Artemisinic acid,"/>
  <result pre="species; however, these drugs may act as hemozoin production inhibitors," exact="folic acid" post="synthesis inhibitors, transcription inhibitors or inhibitors of the mitochondrial"/>
  <result pre="parasite Main Drugs used on treatment Aryl-alcohols: hemozoin production inhibitors" exact="Quinine" post="Mefloquine Halofantrine Pyronaridine Lumefantrine Artemisinin and derivatives: hemozoin production"/>
  <result pre="treatment Aryl-alcohols: hemozoin production inhibitors Quinine Mefloquine Halofantrine Pyronaridine Lumefantrine" exact="Artemisinin" post="and derivatives: hemozoin production inhibitors, mitochondrial respiratory chain inhibitors,"/>
  <result pre="production inhibitors, mitochondrial respiratory chain inhibitors, and transport proteins Artemisin" exact="Artemether" post="Arteether Artesunate Artenilic acid Dihydroartemisin Biguanides and derivatives: folic"/>
  <result pre="mitochondrial respiratory chain inhibitors, and transport proteins Artemisin Artemether Arteether" exact="Artesunate" post="Artenilic acid Dihydroartemisin Biguanides and derivatives: folic acid synthesis"/>
  <result pre="Artemisin Artemether Arteether Artesunate Artenilic acid Dihydroartemisin Biguanides and derivatives:" exact="folic acid" post="synthesis inhibitors Chloroproguanil Cyclochloroproguanil Naphthoquinones: mitochondrial respiratory chain inhibitors"/>
  <result pre="acid synthesis inhibitors Chloroproguanil Cyclochloroproguanil Naphthoquinones: mitochondrial respiratory chain inhibitors" exact="Atovaquone" post="Ubiquinone Quinolines: hemozoin production inhibitors and genetic material (DNA)"/>
  <result pre="hemozoin production inhibitors and genetic material (DNA) modifiers Amodiaquine Primaquine" exact="Chloroquine" post="Etaquine Hydroxychloroquine Plasmoquine Sulfones: inhibitors of folic acid synthesis"/>
  <result pre="inhibitors and genetic material (DNA) modifiers Amodiaquine Primaquine Chloroquine Etaquine" exact="Hydroxychloroquine" post="Plasmoquine Sulfones: inhibitors of folic acid synthesis Dapsone Sulfadoxine"/>
  <result pre="modifiers Amodiaquine Primaquine Chloroquine Etaquine Hydroxychloroquine Plasmoquine Sulfones: inhibitors of" exact="folic acid" post="synthesis Dapsone Sulfadoxine Sulfalene The importance of drugs with"/>
  <result pre="Chloroquine Etaquine Hydroxychloroquine Plasmoquine Sulfones: inhibitors of folic acid synthesis" exact="Dapsone" post="Sulfadoxine Sulfalene The importance of drugs with the quinoline"/>
  <result pre="Etaquine Hydroxychloroquine Plasmoquine Sulfones: inhibitors of folic acid synthesis Dapsone" exact="Sulfadoxine" post="Sulfalene The importance of drugs with the quinoline group"/>
  <result pre="Hydroxychloroquine Plasmoquine Sulfones: inhibitors of folic acid synthesis Dapsone Sulfadoxine" exact="Sulfalene" post="The importance of drugs with the quinoline group (highlighted"/>
  <result pre="of Table 8.1) is highlighted in several drugs, especially synthetic" exact="quinine" post="derivatives that in the last century have achieved significant"/>
  <result pre="therapy, as mentioned in Table 8.1 (Salas et al. 2013)." exact="Chloroquine" post="(CQ) and aminoquinoline were extensively used for many years"/>
  <result pre="exhibit anticancer, anti-allergic, and antiparasitic potential, as they correspond to" exact="nitric oxide" post="donors for vascular relaxation induction (Donnici et al. 2009;"/>
  <result pre="purpose. According to the literature, the binuclear complex of Ru(II)" exact="chloroquine" post="[RuCQCl2]2 (complex 1, Fig. 8.3) was five times more"/>
  <result pre="1, Fig. 8.3) was five times more potent than standard" exact="chloroquine" post="against P. berghei and P. falciparum strains. The mechanism"/>
  <result pre="et al. 2013). Fig. 8.3 Gold and ruthenium complexes of" exact="chloroquine" post="Sanches-Delgado et al. (1996) synthesized the first class of"/>
  <result pre="was investigated (Martínez et al. 2011). Another promising class of" exact="chloroquine" post="complexes for the development of therapeutic agents are gold"/>
  <result pre="of possible ligands that can be coordinated to CQ or" exact="chloroquine" post="diphosphate (CQDP), allowing the investigation of antimalarial properties of"/>
  <result pre="the antimalarial activities of iron, cobalt, and nickel complexes containing" exact="chloroquine" post="(CQ) and Mefloquine (Mef) as ligands. The complexes of"/>
  <result pre="tests revealed that the mixed metal complexes of Mefloquine and" exact="chloroquine" post="[Co(Mef)(CQ)Cl2] and [Fe(Mef)(CQ)Cl3)] exhibited higher antimalarial potential. Furthermore, toxicity"/>
  <result pre="complexes with coordination number equal six (Mabeza et al. 1999)." exact="Desferrioxamine" post="(DFO) is an important representative of iron-chelator and the"/>
  <result pre="therapy. This compound was described in 1997 as the first" exact="chloroquine" post="derivative containing a ferrocene molecule, incorporating the ferrocene to"/>
  <result pre="molecule, incorporating the ferrocene to the lateral side chain of" exact="chloroquine" post="(Biot et al. 1997). Although there are structural similarities"/>
  <result pre="(Biot et al. 1997). Although there are structural similarities between" exact="chloroquine" post="and FQ, the in vitro activities against P. falciparum"/>
  <result pre="C, Delhaes L, Maclejewski AL (2000) Synthetic ferrocene mefloquine and" exact="quinine" post="analogues as potential antimalarial agents. Eur J Med Chem"/>
  <result pre="Dive D, Brocard S J (2000) Synthetic ferrocenic mefloquine and" exact="quinine" post="analogues as potential antimalarial agentes. Eur J Med Chem"/>
  <result pre="the role of the covalent linkage of ferrocene into a" exact="chloroquine" post="template. J Med Chem 49:4707–4714 BlackieALMChibaleKMetallocene antimalarials: the continuing"/>
  <result pre="vitro of new heterobimetallic complexes: Rh and Au derivatives of" exact="chloroquine" post="and a series of ferrocenyl-4-amino-7-chloroquines and a series of"/>
  <result pre="Synthesis and X-ray structural study of novel Ni(II) complexes with" exact="pyridoxal" post="semicarbazone and pyridoxal thiosemicabazonePolyhedron2007262971297810.1016/j.poly.2007.01.041 LessaAJParrilhaLGBeraldoHGallium complexes as new promising"/>
  <result pre="structural study of novel Ni(II) complexes with pyridoxal semicarbazone and" exact="pyridoxal" post="thiosemicabazonePolyhedron2007262971297810.1016/j.poly.2007.01.041 LessaAJParrilhaLGBeraldoHGallium complexes as new promising metallodrugs candidatesInorg Chim"/>
  <result pre="oral iron chelator: 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-oneJ Pharm Pharmacol20156770371310.1111/jphp.1237325627251 PonkaPRichardsonDREdwardJTChubbFLIron chelators of the" exact="pyridoxal" post="isonycotinoyl hydrazone class. Relationship of the lipophilicity of the"/>
  <result pre="Clin Biol Res19893131191492506579 SeuanesGCMoreiraMBPettaTMoraesDMPFMoraesLABOliveiraARMNaalGZMRNikolaouSNovel binuclear μ-oxo diruthenium complexes combined with" exact="ibuprofen" post="and ketoprofen: interaction with relevant target biomolecules and anti-allergic"/>
  <result pre="biomolecules and anti-allergic potentialJ Inorg Biochem201515317818510.1016/j.jinorgbio.2015.08.00426298864 SharmaVTherapeutic drugs for targeting" exact="chloroquine" post="resistance in malariaMini-Rev Med Chem2005533735110.2174/138955705354402915853624 Sibley CH, Ringwald PA"/>
  <result pre="murine malaria parasite Plasmodium bergheiJ Inorg Biochem20171661410.1016/j.jinorgbio.2016.10.00427815977 Van SchalkuykDAWalderJCSmithPJReversal of" exact="chloroquine" post="resistance in Plasmodium falciparum using combinations of chemosensitizersAntimicrob Agents"/>
  <result pre="of actionJ Inorg Biochem20091031300130610.1016/j.jinorgbio.2009.02.01119361864 Wallace DJ (1989) The use of" exact="quinacrine" post="(atrabine) in rheumatic diseases: a reexamination. Semin Arthritis Rheu"/>
 </snippets>
</snippetsTree>
